Sanger Sequencing Market Growth Outlook Through 2024-2033

Overview and Scope
Sanger sequencing, or chain termination sequencing, is a method for determining the nucleotide sequence of DNA. Sanger sequencing is used for smaller-scale initiatives and for validating the outcomes of deep sequencing, as it can create DNA sequence reads of more than 500 nucleotides and maintain accuracy levels.

Sizing and Forecast
The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.29 billion in 2023 to $2.75 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%.  The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.

To access more details regarding this report, visit the link:

Segmentation & Regional Insights
The sanger sequencing market covered in this report is segmented –
1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing
2) By Laboratory: Wet Labs, Dry Labs
3) By Research: In-House, Outsourced
4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

North America was the largest region in the sanger sequencing market in 2023. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

Major Driver Impacting Market Growth
The rise in genetic illness is expected to propel the growth of the sanger sequencing market going forward. A genetic illness, or genetic disorder, is a medical condition caused by abnormalities or mutations in an individual’s DNA, the hereditary material that carries genetic information. Sanger sequencing is used to diagnose genetic illnesses by determining the exact order of nucleotides (the building blocks of DNA) in a specific gene or region of DNA. For instance, in February 2024, according to the Genetic Rare Diseases Information Center (GARD, a US-based government agency, there were about 7,000 known rare genetic diseases, accounting for about 1 in 10 people, or 30 million people in the United States during 2020-2021. Therefore, the rise in genetic illness is driving the growth of the sanger sequencing market.

Key Industry Players
Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

The sanger sequencing market report table of contents includes:
1. Executive Summary

  1. Sanger Sequencing Market Characteristics
  2. Sanger Sequencing Market Trends And Strategies
  3. Sanger Sequencing Market – Macro Economic Scenario
  4. Global Sanger Sequencing Market Size and Growth
  5. Global Sanger Sequencing Market Competitive Benchmarking
  6. Global Sanger Sequencing Market Competitive Dashboard
  7. Key Mergers And Acquisitions In The Sanger Sequencing Market
  8. Sanger Sequencing Market Future Outlook and Potential Analysis
  9. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
Healthcare Blog:
Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *